The preparation of the title compound, [ 3 H 3 ]CNS-5161, was accomplished in three steps starting with the production of [ 3 H 3 ]iodomethane (CT 3 I). The intermediate N-[ 3 H 3 ]methyl-3-(thiomethylphenyl)cyanamide was prepared in 77% yield by the addition of CT 3 I to 3-(thiomethylphenyl)cyanami
Synthesis and characterization of N-(2-chloro-5-methylthiophenyl)-N′-(3-methylthiophenyl)-N′-[11C]methylguanidine [11C]CNS 5161, a candidate PET tracer for functional imaging of NMDA receptors
✍ Scribed by Yongjun Zhao; Edward Robins; David Turton; Frank Brady; Sajinder K. Luthra; Erik Årstad
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- French
- Weight
- 121 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The __N__‐methyl‐D‐aspartate (NMDA) ion channel plays an important role in a number of neurodegenerative disorders including stroke, Parkinson's disease, Huntington's Chorea, Alzheimer's disease, schizophrenia and epilepsy. To provide effective radioligands for imaging the PCP binding s
## Abstract Recently, a new 2‐(iodophenyl)imidazo[1,2‐__a__]pyridineacetamide series has been developed as iodine‐123‐labelled radioligands for imaging the peripheral benzodiazepine receptors using single photon emission tomography. Within this series, 2‐[6‐chloro‐2‐(4‐iodophenyl)‐imidazo[1,2‐__a__
## Abstract A convenient synthesis of [N‐methyl‐^11^C]‐3‐[(6‐dimethylamino)pyridin‐3‐yl]‐2,5‐dimethyl‐__N__,__N__‐dipropylpyrazolo[1,5‐a]pyrimidine‐7‐amine (R121920), a highly selective CRF~1~ antagonist has been developed as a potential PET ligand. 3 ‐ [(6 ‐ methylamino)pyridin ‐ 3 ‐ yl]‐2,5‐dimet
## Abstract Two novel ligands for cerebral cannabinoid receptor (CB1), 1‐(2,4‐dichlorophenyl)‐4‐cyano‐5‐(4‐methoxyphenyl)‐__N__‐(piperidin‐1‐yl)‐1__H__‐pyrazole‐3‐carboxamide (JHU75528) and 1‐(2‐bromophenyl)‐4‐cyano‐5‐(4‐methoxyphenyl)‐__N__‐(piperidin‐1‐yl)‐1__H__‐pyrazole‐3‐carboxamide (JHU75575)